An empirical study using permutation-based resampling in meta-regression

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Gagnier, Joel J ^a,b   Moher, David ^c,d   Boon, Heather ^e   Bombardier, Claire ^f   Beyene, Joseph ^g  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; DEMENTIA; DEPRESSION; EMPIRICISM; GARLIC; GINKGO BILOBA; HAMILTON SCALE; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; META ANALYSIS (TOPIC); METHODOLOGY; OUTCOME ASSESSMENT; PROSTATE HYPERTROPHY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SABAL; SAMPLING; REGRESSION ANALYSIS; SAMPLE SIZE; STATISTICS;

HERBAL MEDICINE; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84875365439     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-18     Document Type: Article

References (32)

1. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002, 21:1539-1558.
2. Cochrane Handbook for Systematic Reviews of Interventions of interventions 5.0.0. Higgins JPT, Green S., http://www.cochrane-handbook.org
3. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007, 36:847-857. 10.1093/ije/dym087, 17517809.
4. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Statist Med 2004, 23:1663-1682.
5. Huang Y, Xu H, Calian V, Hsu JC. To permute or not to permute. Bioinformatics 2006, 22:2244-2248. 10.1093/bioinformatics/btl383, 16870938.
6. Gagnier JJ, Rochon PA, Boon H, Barnes J, Moher D, Bombardier C, for the CONSORT Group Improving the reporting of randomized controlled trials of herbal medicine interventions: an application of the CONSORT statement. Ann Intern Med 2006, 144:364-367. for the CONSORT Group.
7. Linde K, ter Riet G, Hondras M, Melchart D, Willich SN. Characteristics and quality of systematic reviews of acupuncture, herbal medicines and homeopathy. Forsch Komplmentarmed Klass Natureheilkd 2003, 10:88-94.
8. Gagnier JJ, DeMelo J, Boon H, Rochon P, Bombardier C. Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med 2006, 119:800.
9. Concato J, Peduzzi P, Holfold TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol 1995, 48:1495-1501. 10.1016/0895-4356(95)00510-2, 8543963.
10. Peduzzi P, Concato J, Feinstein AR, Holfold TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995, 48:1503-1510. 10.1016/0895-4356(95)00048-8, 8543964.
11. Peduzzi P, Concato J, Kemper E, Holfold TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379. 10.1016/S0895-4356(96)00236-3, 8970487.
12. The Cochrane Collaboration The Cochrane Manual Issue 4, 2008. The Cochrane Collaboration., http://www.cochrane.org/admin/manual.htm
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
14. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Higgins JPT, Green S., http://www.cochrane-handbook.org
15. Cochran WG. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
16. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Stat Med 1991, 10:1665-1677. 10.1002/sim.4780101105, 1792461.
17. Moher D, Tetzlaff J, Tricco AC, Sampson N, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007, 4:e78. 10.1371/journal.pmed.0040078, 1831728, 17388659.
18. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7:51-61. 10.1258/1355819021927674, 11822262.
19. Petittie DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001, 20:3625-3633. 10.1002/sim.1091, 11746342.
20. Xu H, Platt RW, Luo Z, Wei S, Fraser WD. Exploring heterogeneity in meta-analyses: needs, resources and challenges. Paediatr Perinat Epidemiol 2008, 21:18-28.
21. Schmid CH, Stark PC, Berlin JA, Landais P, Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, not patient-level, factors. J Clin Epi 2004, 57:683-697.
22. Flack V, Change PC. Frequency of selecting noise variables in subset regression analysis: a simulation study. Am Stat 1989, 41:84-86.
23. Freedman LS, Pee D. Return to a note on screening regression equations. Am Stat 1989, 43:279-282.
24. Freedman LS, Pee D, Midthune DN. The problem of understanding the residual error variance in forward stepwise regression. Statistician 1992, 41:405-412.
25. Berlin JA, Antman EM. Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials 1994, 4:134.
26. Davey Smith G, Egger M, Phillips AN. Meta-analysis: beyond the grand mean?. BMJ 1997, 315:1610-1614. 10.1136/bmj.315.7122.1610, 2127994, 9437284.
27. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998, 351:123-127. 10.1016/S0140-6736(97)08468-7, 9439507.
28. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002, 21:1559-1574. 10.1002/sim.1187, 12111920.
29. Kunz R, Vist GE, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2007, 2:MR000012.
30. Verhagen AP, De Bie RA, Lenssen AF, de Vet HC, Kessels AG, Boers M, van den Brandt PA. Impact of quality items on study outcome. Int J Technol Assess Healthcare 2000, 16:1136-1146.
31. Linde K, Mulrow CD, Berner M, Egger M. St John's Wort for depression. Cochrane Database Syst Rev 2005, 2:CD000448.
32. Linde K, Mulrow CD, Berner M, Egger M. St John's Wort for depression. Cochrane Database Syst Rev 2008, 4:CD000448.